ES2131185T3 - Arilalcanil-n-hidroxiureas y heteroalquilalcanil-n-hidroxiureas sustituidas que pueden inhibir la biosintesis de leucotrienos. - Google Patents
Arilalcanil-n-hidroxiureas y heteroalquilalcanil-n-hidroxiureas sustituidas que pueden inhibir la biosintesis de leucotrienos.Info
- Publication number
- ES2131185T3 ES2131185T3 ES94902209T ES94902209T ES2131185T3 ES 2131185 T3 ES2131185 T3 ES 2131185T3 ES 94902209 T ES94902209 T ES 94902209T ES 94902209 T ES94902209 T ES 94902209T ES 2131185 T3 ES2131185 T3 ES 2131185T3
- Authority
- ES
- Spain
- Prior art keywords
- hidroxiureas
- pct
- inhibit
- compounds
- heteroalquilalcanil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS QUE TIENE ACTIVIDAD PARA INHIBIR LA ACTIVIDAD DE LA ENZIMA LIPOXIGENASA, PARA COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN ESTOS COMPUESTOS Y PARA UN METODO DE TRATAMIENTO MEDICO. MAS PARTICULARMENTE, ESTA INVENCION SE REFIERE A CIERTAS ARILOALQUINILO-Y HETEROARILOALQUINILO-N-HIDROXIUREAS SUBSTITUIDAS LAS CUALES INHIBEN LA BIOSINTESIS LEUCOTRIENO, PARA COMPOSICIONES FARMACEUTICAS DE ESTOS COMPUESTOS Y A UN METODO DE INHIBICION DE LA BIOSINTESIS LEUCOTRIENO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/973,100 US5288751A (en) | 1992-11-06 | 1992-11-06 | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
PCT/US1993/010675 WO1994011342A1 (en) | 1992-11-06 | 1993-11-05 | Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2131185T3 true ES2131185T3 (es) | 1999-07-16 |
Family
ID=25520498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94902209T Expired - Lifetime ES2131185T3 (es) | 1992-11-06 | 1993-11-05 | Arilalcanil-n-hidroxiureas y heteroalquilalcanil-n-hidroxiureas sustituidas que pueden inhibir la biosintesis de leucotrienos. |
Country Status (14)
Country | Link |
---|---|
US (2) | US5288751A (es) |
EP (1) | EP0667855B1 (es) |
JP (1) | JPH08503200A (es) |
KR (1) | KR100322641B1 (es) |
AT (1) | ATE178049T1 (es) |
AU (1) | AU673040B2 (es) |
CA (1) | CA2136077A1 (es) |
DE (1) | DE69324152T2 (es) |
DK (1) | DK0667855T3 (es) |
ES (1) | ES2131185T3 (es) |
GR (1) | GR3030354T3 (es) |
IL (1) | IL107505A (es) |
PH (1) | PH30162A (es) |
WO (1) | WO1994011342A1 (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5476873A (en) * | 1990-07-25 | 1995-12-19 | Abbott Laboratories | Acetylene derivatives having lipoxygenase inhibitory activity |
US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
DE69329550T2 (de) | 1992-07-13 | 2001-05-31 | Cytomed Inc | 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten |
US5288751A (en) * | 1992-11-06 | 1994-02-22 | Abbott Laboratories | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
WO1995012589A1 (en) * | 1993-11-05 | 1995-05-11 | Abbott Laboratories | Process for the preparation of n-4-[(substituted phenyl)alkylthienyl]-, and n-4-[(substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds |
US5506261A (en) * | 1994-05-09 | 1996-04-09 | Abbott Laboratories | Substituted aryl- and heteroarylalkenyl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
JP3179286B2 (ja) * | 1994-05-19 | 2001-06-25 | ファイザー製薬株式会社 | N−ヒドロキシ尿素系抗炎症剤 |
US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
MX9606635A (es) * | 1994-06-27 | 1997-12-31 | Cytomed Inc | Compuestos y metodos para el tratamiento de desordenes cardiovasculares, inflamatorios e inmunes. |
US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5750565A (en) * | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
FR2721610B1 (fr) * | 1994-06-28 | 1996-08-23 | Adir | Nouveaux dérivés (thia)cycloalkyl [b] indoles, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
DE4444862A1 (de) * | 1994-12-16 | 1996-06-20 | Bayer Ag | Verfahren zur Herstellung von Methylenverbindungen und die neue Verbindung 2-(2',4'-Dichlor-5-fluorbenzyl)-thiophen |
US5516789A (en) * | 1995-04-12 | 1996-05-14 | Abbott Laboratories | Lipoxygenase and cyclooxygenase inhibiting compounds |
AU5347496A (en) * | 1995-04-21 | 1996-11-07 | Daiichi Pharmaceutical Co., Ltd. | Ethynylthiazole derivative |
ATE301457T1 (de) * | 1995-06-12 | 2005-08-15 | Searle & Co | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
US5714633A (en) * | 1995-09-12 | 1998-02-03 | Abbott Laboratories | Process for the preparation of arylalkynyl-N-hydroxyurea derivatives having lipoxygenase inhibitory activity |
DE69715382T2 (de) | 1996-02-13 | 2003-04-30 | Searle & Co | Arzneimittelkombinationen mit immunosuppressiven wirkungen welche cyclooxygenase-2 inhibitoren und leukotrien lta4 hydrase-inhibitoren enthalten |
EP0888127B1 (en) | 1996-02-13 | 2001-12-12 | G.D. Searle & Co. | Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors |
US6005000A (en) * | 1996-08-22 | 1999-12-21 | Oxis International, Inc. | 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor |
WO1998058645A1 (en) * | 1997-06-24 | 1998-12-30 | Sepracor, Inc. | (s)-(-)-n-[3- [5-[(4-fluorophenyl)methyl] -2-thienyl]-1-methyl -2-propynyl]-n-hydroxyurea |
US5925769A (en) * | 1997-09-09 | 1999-07-20 | Ortho Pharmaceutical, Corp. | Acetylenic 1,5-diarylpyrazoles as antiinflammatory agents |
EP1094805A4 (en) | 1998-07-03 | 2002-08-28 | Millennium Pharm Inc | ALICYCLIC COMPOUNDS WITH SUBSTITUTED OXYGEN ATOM, AND THEIR PREPARATION METHOD |
MXPA01000234A (es) | 1998-07-03 | 2003-02-10 | Millennium Pharm Inc | Metodos para la sintesis de compuesto de tetrahidrofurano substituido. |
US6255498B1 (en) | 1998-10-16 | 2001-07-03 | Millennium Pharmaceuticals, Inc. | Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans |
PE20001566A1 (es) | 1999-03-26 | 2001-02-05 | Ucb Sa | Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas |
US6686502B1 (en) | 1999-03-26 | 2004-02-03 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
US6894059B1 (en) | 1999-03-26 | 2005-05-17 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
MXPA04006709A (es) | 2002-01-11 | 2004-10-04 | Sankyo Co | Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen. |
AU2003249539A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
US20080293750A1 (en) * | 2002-10-17 | 2008-11-27 | Anna Helgadottir | Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment |
US20100216863A1 (en) * | 2004-01-30 | 2010-08-26 | Decode Genetics Ehf. | Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment |
US8158362B2 (en) * | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
WO2005079788A1 (ja) | 2004-02-24 | 2005-09-01 | Sankyo Company, Limited | アミノアルコール化合物 |
US7495024B2 (en) * | 2006-08-07 | 2009-02-24 | Via Pharmaceuticals, Inc. | Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque |
EP3791880A1 (en) | 2009-04-29 | 2021-03-17 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa |
US20120029048A1 (en) * | 2010-07-30 | 2012-02-02 | Via Pharmaceuticals, Inc. | Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies |
WO2016149126A1 (en) | 2015-03-13 | 2016-09-22 | The Board Of Trustees Of The Leland Stanford Junior University | Ltb4 inhibition to prevent and treat human lymphedema |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE59397B1 (en) * | 1985-03-16 | 1994-02-23 | Wellcome Found | New aryl derivatives |
JPH0819069B2 (ja) * | 1990-07-25 | 1996-02-28 | アボツト・ラボラトリーズ | リポキシゲナーゼ阻害活性を有するアセチレン誘導体 |
DE4023742A1 (de) * | 1990-07-26 | 1992-01-30 | Gruenenthal Gmbh | Substituierte phenylacetylene, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
JPH06256285A (ja) * | 1990-12-11 | 1994-09-13 | Pfizer Pharmaceut Co Ltd | ヒドロキサム酸誘導体およびその用途 |
US5214204A (en) * | 1991-07-19 | 1993-05-25 | Abbott Laboratories | Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity |
US5288751A (en) * | 1992-11-06 | 1994-02-22 | Abbott Laboratories | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
-
1992
- 1992-11-06 US US07/973,100 patent/US5288751A/en not_active Expired - Lifetime
-
1993
- 1993-11-05 DE DE69324152T patent/DE69324152T2/de not_active Expired - Lifetime
- 1993-11-05 KR KR1019940704341A patent/KR100322641B1/ko not_active IP Right Cessation
- 1993-11-05 CA CA002136077A patent/CA2136077A1/en not_active Abandoned
- 1993-11-05 IL IL10750593A patent/IL107505A/xx not_active IP Right Cessation
- 1993-11-05 DK DK94902209T patent/DK0667855T3/da active
- 1993-11-05 WO PCT/US1993/010675 patent/WO1994011342A1/en active IP Right Grant
- 1993-11-05 AU AU56660/94A patent/AU673040B2/en not_active Ceased
- 1993-11-05 AT AT94902209T patent/ATE178049T1/de not_active IP Right Cessation
- 1993-11-05 US US08/416,807 patent/US5616596A/en not_active Expired - Fee Related
- 1993-11-05 ES ES94902209T patent/ES2131185T3/es not_active Expired - Lifetime
- 1993-11-05 EP EP94902209A patent/EP0667855B1/en not_active Expired - Lifetime
- 1993-11-05 JP JP6511496A patent/JPH08503200A/ja not_active Ceased
- 1993-11-15 PH PH47213A patent/PH30162A/en unknown
-
1999
- 1999-05-27 GR GR990401443T patent/GR3030354T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5616596A (en) | 1997-04-01 |
EP0667855A1 (en) | 1995-08-23 |
WO1994011342A1 (en) | 1994-05-26 |
DE69324152D1 (en) | 1999-04-29 |
ATE178049T1 (de) | 1999-04-15 |
AU673040B2 (en) | 1996-10-24 |
PH30162A (en) | 1997-01-21 |
CA2136077A1 (en) | 1994-05-26 |
DE69324152T2 (de) | 1999-10-28 |
KR950702180A (ko) | 1995-06-19 |
KR100322641B1 (ko) | 2002-06-20 |
JPH08503200A (ja) | 1996-04-09 |
GR3030354T3 (en) | 1999-09-30 |
IL107505A (en) | 2000-07-26 |
EP0667855B1 (en) | 1999-03-24 |
EP0667855A4 (en) | 1996-02-21 |
US5288751A (en) | 1994-02-22 |
DK0667855T3 (da) | 1999-10-11 |
IL107505A0 (en) | 1994-02-27 |
AU5666094A (en) | 1994-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2131185T3 (es) | Arilalcanil-n-hidroxiureas y heteroalquilalcanil-n-hidroxiureas sustituidas que pueden inhibir la biosintesis de leucotrienos. | |
ATE307119T1 (de) | Bicyclische protein-farnesyl-transferase inhibitoren | |
ES2136723T3 (es) | Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante. | |
UA35589C2 (uk) | ІНГІБІТОРИ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ІНГІБУВАННЯ АКТИВНОСТІ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ | |
MX9307185A (es) | Derivados de carboxilato de indol que inhiben la biosintesis del leucotrieno y composiciones farmaceuticas que los contienen. | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
ES2113652T3 (es) | Pamoato de risperidona. | |
BR0200923A (pt) | Composições que contêm produtos derivados de leguminosas | |
IL110943A (en) | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders | |
BR9707353A (pt) | Preparações que promovem o crescimento de unhas | |
EA199800355A1 (ru) | Синергетическая фунгицидная композиция, содержащая соединение-аналог стробилурина | |
CZ157795A3 (en) | Pharmaceutical preparations for treating prostatitis | |
MX9307996A (es) | Derivados de oxima eter que tienen actividad inhibidora de lipoxigenasa. | |
DK0722325T3 (da) | Præparat til behandling eller forebyggelse af herpes | |
EP0645963A4 (es) | ||
PT971714E (pt) | Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia | |
AU5857899A (en) | Use of tgf-beta inhibitors for treating cerebral disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 667855 Country of ref document: ES |